Insiders · Profile

Ambrose Kristen

SVP & Chief Accounting Officer at Vertex Pharmaceuticals. Filing since 25 Apr 2022. CIK 0001856587

Company

Date

Role

Action

Shares

Amount

Of holding

VRTX Vertex Pharmaceuticals

26 Feb 2026

SVP & Chief Accounting Officer

Sold on a plan

357

$172.56K

5.1%

VRTX Vertex Pharmaceuticals

25 Feb 2026

SVP & Chief Accounting Officer

Sold on a plan

223

$108.46K

3.1%

VRTX Vertex Pharmaceuticals

18 Feb 2026

SVP & Chief Accounting Officer

Sold on a plan

638

$302.21K

7.6%

VRTX Vertex Pharmaceuticals

17 Feb 2026

SVP & Chief Accounting Officer

Sold on a plan

1,557

$762.09K

15.7%

VRTX Vertex Pharmaceuticals

11 Feb 2026

SVP & Chief Accounting Officer

Sold on a plan

1,376

$633.55K

12.0%

VRTX Vertex Pharmaceuticals

25 Feb 2025

SVP & Chief Accounting Officer

Sold on a plan

884

$425.16K

8.9%

VRTX Vertex Pharmaceuticals

18 Feb 2025

SVP & Chief Accounting Officer

Sold on a plan

671

$305.35K

5.9%

VRTX Vertex Pharmaceuticals

11 Feb 2025

SVP & Chief Accounting Officer

Sold on a plan

1,376

$632.73K

12.1%

VRTX Vertex Pharmaceuticals

2 Apr 2024

SVP & Chief Accounting Officer

Sold on a plan

240

$100.56K

3.1%

VRTX Vertex Pharmaceuticals

26 Feb 2024

SVP & Chief Accounting Officer

Sold on a plan

883

$375.89K

10.0%

VRTX Vertex Pharmaceuticals

12 Feb 2024

SVP & Chief Accounting Officer

Sold on a plan

1,374

$577.41K

12.4%

VRTX Vertex Pharmaceuticals

30 May 2023

SVP & Chief Accounting Officer

Sold on a plan

289

$95.32K

4.1%

VRTX Vertex Pharmaceuticals

27 Feb 2023

SVP & Chief Accounting Officer

Sold, plan not stated

1,207

$347.07K

14.2%

VRTX Vertex Pharmaceuticals

25 Apr 2022

SVP & Chief Accounting Officer

Sold, plan not stated

327

$88.14K

8.6%

14 decisions on file.